These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 21996525)

  • 21. Six-month compliance with antidepressant medication in the treatment of major depressive disorder.
    Demyttenaere K; Adelin A; Patrick M; Walthère D; Katrien de B; Michèle S
    Int Clin Psychopharmacol; 2008 Jan; 23(1):36-42. PubMed ID: 18090506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A retrospective investigation of the relationship between baseline covariates and rate of ALSFRS-R decline in ALS clinical trials.
    Daghlas I; Lever TE; Leary E
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 May; 19(3-4):206-211. PubMed ID: 29260911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A clinical pilot study: high frequency chest wall oscillation airway clearance in patients with amyotrophic lateral sclerosis.
    Chaisson KM; Walsh S; Simmons Z; Vender RL
    Amyotroph Lateral Scler; 2006 Jun; 7(2):107-11. PubMed ID: 16753975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intent-to-treat analysis for longitudinal studies with drop-outs.
    Little R; Yau L
    Biometrics; 1996 Dec; 52(4):1324-33. PubMed ID: 8962456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized, placebo-controlled trial of memantine for functional disability in amyotrophic lateral sclerosis.
    de Carvalho M; Pinto S; Costa J; Evangelista T; Ohana B; Pinto A
    Amyotroph Lateral Scler; 2010 Oct; 11(5):456-60. PubMed ID: 20565333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The changes of clinical characteristics in 100 Japanese amyotrophic lateral sclerosis patients between 1980 and 2000].
    Kimura F; Shinoda K; Fujiwara S; Fujimura C; Nakajima H; Furutama D; Sugino M; Hanafusa T
    Rinsho Shinkeigaku; 2003 Jul; 43(7):385-91. PubMed ID: 14582363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications.
    Khin NA; Chen YF; Yang Y; Yang P; Laughren TP
    J Clin Psychiatry; 2011 Apr; 72(4):464-72. PubMed ID: 21527123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Missing data handling in chronic pain trials.
    Kim Y
    J Biopharm Stat; 2011 Mar; 21(2):311-25. PubMed ID: 21391004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS.
    Kimura F; Fujimura C; Ishida S; Nakajima H; Furutama D; Uehara H; Shinoda K; Sugino M; Hanafusa T
    Neurology; 2006 Jan; 66(2):265-7. PubMed ID: 16434671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The case of the missing data: methods of dealing with dropouts and other research vagaries.
    Streiner DL
    Can J Psychiatry; 2002 Feb; 47(1):68-75. PubMed ID: 11873711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A two-stage design for a phase II clinical trial of coenzyme Q10 in ALS.
    Levy G; Kaufmann P; Buchsbaum R; Montes J; Barsdorf A; Arbing R; Battista V; Zhou X; Mitsumoto H; Levin B; Thompson JL
    Neurology; 2006 Mar; 66(5):660-3. PubMed ID: 16534103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On the performance of random-coefficient pattern-mixture models for non-ignorable drop-out.
    Demirtas H; Schafer JL
    Stat Med; 2003 Aug; 22(16):2553-75. PubMed ID: 12898544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An alternative parameterization of the general linear mixture model for longitudinal data with non-ignorable drop-outs.
    Fitzmaurice GM; Laird NM; Shneyer L
    Stat Med; 2001 Apr; 20(7):1009-21. PubMed ID: 11276032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Partial imputation approach to analysis of repeated measurements with dependent drop-outs.
    Wei L; Shih WJ
    Stat Med; 2001 Apr; 20(8):1197-214. PubMed ID: 11304736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can selection of rapidly progressing patients shorten clinical trials in amyotrophic lateral sclerosis?
    de Carvalho M; Swash M
    Arch Neurol; 2006 Apr; 63(4):557-60. PubMed ID: 16606769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Performance of weighted estimating equations for longitudinal binary data with drop-outs missing at random.
    Preisser JS; Lohman KK; Rathouz PJ
    Stat Med; 2002 Oct; 21(20):3035-54. PubMed ID: 12369080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple imputation under Bayesianly smoothed pattern-mixture models for non-ignorable drop-out.
    Demirtas H
    Stat Med; 2005 Aug; 24(15):2345-63. PubMed ID: 15977286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and evaluation of a self-administered version of the ALSFRS-R.
    Montes J; Levy G; Albert S; Kaufmann P; Buchsbaum R; Gordon PH; Mitsumoto H
    Neurology; 2006 Oct; 67(7):1294-6. PubMed ID: 17030772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fetal olfactory ensheathing cells transplantation in amyotrophic lateral sclerosis patients: a controlled pilot study.
    Huang H; Chen L; Xi H; Wang H; Zhang J; Zhang F; Liu Y
    Clin Transplant; 2008; 22(6):710-8. PubMed ID: 18673377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A bias correction in testing treatment efficacy under informative dropout in clinical trials.
    Kong F; Chen YF; Jin K
    J Biopharm Stat; 2009 Nov; 19(6):980-1000. PubMed ID: 20183460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.